| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Teva Pharmaceutical Industries Limited (TEVA) have been net sellers, shedding 403,419 shares worth roughly $15.7M on balance.
TEVA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.12M | - | - | |
| CEO | 1.18M | $40.45M | - | |
| Dir | 448.0K | - | - | |
| Other | 134.9K | $4.70M | - | |
| Dir | 130.1K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Francis Richard D | President and CEO | Sale+OE10b5-1 | 6,153 | $34.35 | $211,355.55 | -0.5% | +7.1% | - | |
| Jun 3, 2026 | Shields Matthew | EVP, Global Operations | Sale+OE10b5-1 | 16,195 | $32.87 | $532,329.65 | -61.9% | +10.2% | - | |
| May 14, 2026 | Lippman Evan | EVP, Business Development | Sale+OE10b5-1 | 41,658 | $35.58 | $1,482,366.60 | -48.5% | +4.0% | - | |
| May 14, 2026 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell10b5-1 | 153,251 | $35.61 | $5,457,375.39 | -47.1% | +4.0% | - | |
| May 6, 2026 | Weiss Amir | Chief Accounting Officer | Sell | 10,679 | $36.00 | $384,444.00 | -34.8% | -5.3% | - | |
| May 5, 2026 | Daniell Richard | EVP, Europe Commercial | Sell | 30,000 | $35.40 | $1,062,000.00 | -35.0% | -3.9% | - | |
| May 1, 2026 | Sabag Mark | See "remarks" | Sell | 144,180 | $34.99 | $5,045,117.72 | -64.1% | +1.3% | - | |
| Apr 30, 2026 | Fox Christine | EVP, U.s. Commercial | Sell | 21,258 | $35.31 | $750,619.98 | -25.0% | -1.0% | - | |
| Mar 17, 2026 | Sabag Mark | See "remarks" | Sell | 62,102 | $30.14 | $1,871,816.38 | -21.6% | +12.0% | - | |
| Mar 5, 2026 | Savage Brian | Interim Chief Legal Officer | Sale+OE | 1,127 | $31.67 | $35,690.29 | -9.4% | +3.4% | - |